Venous Stents Market
Venous Stents Market 2025 to 2035
The global venous stents market is projected to experience robust growth, reaching USD 3.2 billion by 2035, up from USD 1.99 billion in 2025, with an estimated CAGR of 9.4% during the forecast period. The increasing prevalence of venous diseases, rising adoption of minimally invasive procedures, and advancements in stent materials are key drivers fueling market expansion.
Market Overview
| Market Aspect |
Details |
|---|---|
|
Market Value (2025) |
USD 1.99 Billion |
|
Market Value (2035) |
USD 3.2 Billion |
|
CAGR (2025-2035) |
9.4% |
|
Top 5 Countries’ Share |
55.8% |
|
Leading Players |
Becton Dickinson, Cook Group Inc., Boston Scientific, Medtronic, Koninklijke Philips N.V., Abbott Laboratories, and others |
Key Market Dynamics
Rising Prevalence of Venous Disorders Driving Demand
Venous stents are used to treat chronic venous insufficiency, deep vein thrombosis (DVT), and venous stenosis. The growing incidence of DVT and post-thrombotic syndrome (PTS) due to sedentary lifestyles, aging populations, and obesity has led to increased demand for effective vascular treatments.
Market Segmentation & Category Analysis
By Material Type:
| Material Type |
Market Share (2025) |
|---|---|
|
Nitinol |
90.2% |
|
Elgiloy |
9.8% |
Nitinol-based venous stents dominate the market due to their flexibility, biocompatibility, and high radial strength.
By Indication:
| Indication |
Market Share (2025) |
|---|---|
|
Chronic Deep Vein Thrombosis |
43.6% |
|
Post-Thrombotic Syndrome (PTS) |
30.2% |
|
May-Thurner’s Syndrome (MTS) |
18.7% |
|
Pelvic Congestion Syndrome (PCS) |
7.5% |
Chronic DVT remains the most common indication, followed by PTS and MTS, both of which require long-term venous support.
By End-User:
| End-User |
Market Share (2025) |
|---|---|
|
Hospitals |
35.9% |
|
Ambulatory Surgery Centers |
32.4% |
|
Specialty Clinics |
31.7% |
Hospitals lead the segment, but ambulatory surgery centers (ASCs) are rapidly expanding due to cost-effective outpatient procedures.
Regional Insights & Growth Opportunities
United States:
- Holds 34.8% of the market, supported by high healthcare spending and widespread adoption of venous stenting procedures.
- 900,000 individuals are affected by DVT or pulmonary embolism (PE) annually, driving demand for stent interventions.
Europe:
- Accounts for 26.2% of market share, led by Germany, France, and the UK.
- Increasing government funding for vascular disease research is promoting the adoption of advanced venous stents.
Asia-Pacific:
- Expected to grow at CAGR 10.1%, fueled by rising healthcare investments and increasing incidences of venous diseases in China, Japan, and India.
- Regulatory approvals, such as China’s NMPA, are supporting smooth market entry for foreign stent manufacturers.
Challenges & Market Restraints
- High cost of venous stents limits accessibility in developing nations.
- Regulatory complexities and long approval timelines delay new product launches.
- Risk of stent-related complications, including migration, fracture, and thrombosis, remains a concern.
Competitive Landscape & Recent Developments
Leading companies in the venous stents market are expanding product portfolios, securing regulatory approvals, and engaging in mergers and acquisitions.
Recent Developments:
- In 2025, Becton Dickinson reintroduced its Venovo venous stent after addressing previous recall issues.
- Philips acquired Vesper Medical, enhancing its vascular product line for deep vein treatments.
- Boston Scientific launched a next-gen hybrid stent, offering enhanced flexibility and radial force.
Frequently Asked Questions (FAQs)
- What is the projected market size of venous stents by 2035?
- The market is expected to reach USD 3.2 billion by 2035.
- What is the market CAGR from 2025 to 2035?
- The market is projected to grow at a CAGR of 9.4%.
- Which region holds the largest market share?
- The U.S. leads the market with a 34.8% share.
- What are the key challenges affecting market growth?
- High costs, complex regulatory approvals, and risk of stent-related complications.
- Who are the leading players in the venous stents market?
- Becton Dickinson, Cook Group Inc., Boston Scientific, Medtronic, Koninklijke Philips N.V., Abbott Laboratories, and more.
Take Action Now!
Contact us today to access the full report and gain strategic insights to expand your business!